With new guidance following reports of rare blood clots, the global medical community is considering whether it’s possible, and safe, to administer two different vaccine candidates to the same person. This week the European Medicines Agency and the U.K.’s Medicines and Healthcare products Regulatory Agency both determined that there is a possible link between the… Read More »
The national temperature should have been cooled yesterday following MHRA’s conclusion that AstraZeneca vaccine-linked blood clots are extremely rare. Despite attempts to allay fears, many people getting the vaccine will be worried. Speaking on Good Morning Britain (GMB), Dr Amir Khan highlighted the telltale signs the vaccine is causing a clot. “If symptoms resolve after… Read More »
FDA Approves Qelbree (viloxazine) for the Treatment of ADHD ROCKVILLE, Md., April 02, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the U.S. Food and Drug Administration (FDA) approved Qelbree (viloxazine extended-release capsules) for the treatment of attention-deficit hyperactivity… Read More »
Calls are mounting for the Biden administration to set up a national tracking system of covid-19 deaths among front-line health care workers to honor the thousands of nurses, doctors and support staffers who have died and ensure that future generations are not forced to make the same ultimate — and, in many cases, needless —… Read More »